Danaher Prices €1.7 Billion Offering of Senior Notes

Mar 26, 2020

|

NEW YORK – Danaher announced Wednesday that it has priced its offering of €1.7 billion ($1.9 billion) senior notes.

The offering consists of €750 million principal amount of 1.7 percent senior notes due 2024; €500 million principal amount of 2.1 percent senior notes due 2026; and €500 million principal amount of 2.5 percent senior notes due 2030.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

Danaher Prices €1.7 Billion Offering of Senior Notes

To read the full story....

Breaking News

Alzheimer's Disease Linked to Epigenetic Changes in Multi-Omic Study

Zymo Research Gets CE-IVD Mark for Sample Collection Devices

Ceres Nanosciences Nabs $243K SBIR Grant to Adapt RNA Capture Tech for Portable Sequencing

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

Top Five Articles on GenomeWeb Last Week: Illumina, Exact Sciences, Grail, and More

FDA Updates Emergency Use Authorization for Hologic SARS-CoV-2 Assay for Asymptomatic Testing

The Scan

This Time, Novavax

Shortened Visas for Some Students

New York's Own Review

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

What's Popular?

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

Catalog DNA Merges Molecular Biology, Information Theory to Pursue DNA-Based Computing

Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

Ionpath Expanding Sales Force, Investing in Informatics Tools Development

Sponsorships